◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HDFC Life Insurance Company Limited (HDFCLIFE) Revenue 2023–TTM

Name: HDFC Life Insurance Company Limited (HDFCLIFE) revenue history 2023-TTM
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

DATA UPDATED 2026-11-02

HDFC Life Insurance Company Limited annual revenue for fiscal TTM was ₹1.07 trillion, an increase of 17.3% from ₹916.1 billion in fiscal 2026. All figures are reported results from public filings — no estimates or projections.

HDFCLIFE Annual Revenue

Revenue (annual)	TTM → 2026-09-30	2026-03-31	2025-03-31	2024-03-31	2023-03-31
Total Revenue	₹1.07T	₹916.1B	₹900.7B	₹958.2B	₹702.5B

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

HDFCLIFE Quarterly Revenue

Revenue (quarterly)	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-06-30	2025-03-31
Total Revenue	₹244.9B	₹337.3B	₹198.2B	₹294.2B	₹294.7B	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Revenue at Comparable Companies

LICI Revenue — Life Insurance Corporation of India
8795 Revenue — T&D Holdings, Inc.
7181 Revenue — Japan Post Insurance Co., Ltd.
SBILIFE Revenue — SBI Life Insurance Company Limited
8729 Revenue — Sony Financial Group Inc.
2318 Revenue — Ping An Insurance (Group) Company of China, Ltd.

More HDFCLIFE metrics: Net Income · EPS · Free Cash Flow

All HDFCLIFE financial statements → Interactive HDFCLIFE charts →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.